Skip to content
naulon
Get started

No retraction, correction or concern found when last checked on Nov 2, 2026.

DDR1-induced neutrophil extracellular traps drive pancreatic cancer metastasis

Jenying Deng, Yaan Kang, Chien-Chia Cheng and 9 more (opens in a new tab)

JCI Insight · 2021 · CC BY

doi:10.1101/2020.08.05.238097 (opens in a new tab)

Abstract

Pancreatic ductal adenocarcinoma (PDAC) tumors are characterized by a desmoplastic reaction resulting in dense deposition of collagen that is known to promote cancer progression. A central mediator of protumorigenic collagen signaling is the receptor tyrosine kinase discoid domain receptor 1 (DDR1). DDR1 is a critical driver of a mesenchymal and invasive cancer cell PDAC phenotype. Previous studies have demonstrated that genetic or pharmacologic inhibition of DDR1 reduces PDAC tumorigenesis and metastasis. Here, we investigated whether DDR1 signaling has cancer cell nonautonomous effects that promote PDAC progression and metastasis. We demonstrate that collagen-induced DDR1 activation in cancer cells is a major stimulus for CXCL5 production, resulting in the recruitment of tumor-associated neutrophils (TANs), the formation of neutrophil extracellular traps (NETs), and subsequent cancer cell invasion and metastasis. Moreover, we have identified that collagen-induced CXCL5 production was mediated by a DDR1/PKC θ /SYK/NF- κ B signaling cascade. Together, these results highlight the critical contribution of the collagen I–DDR1 interaction in the formation of an immune microenvironment that promotes PDAC metastasis.

References 66

  1. 1.

    Neoptolemos JP, et al. Therapeutic developments in pancreatic cancer: current and future perspectives. Nat Rev Gastroenterol Hepatol. 2018;15(6):333-348.

    Not in our library10.1038/s41575-018-0005-x (opens in a new tab)

  2. 2.

    Rahib L, et al. Projecting cancer incidence and deaths to 2030: the unexpected burden of thyroid, liver, and pancreas cancers in the United States. Cancer Res. 2014;74(11):2913-2921.

    Not in our library10.1158/0008-5472.can-14-0155 (opens in a new tab)

  3. 3.

    Hosein AN, et al. Pancreatic cancer stroma: an update on therapeutic targeting strategies. Nat Rev Gastroenterol Hepatol. 2020;17(8):487-505.

    Not in our library10.1038/s41575-020-0300-1 (opens in a new tab)

  4. 4.

    Huang H, et al. Extracellular matrix induction of intracellular reactive oxygen species. Antioxid Redox Signal. 2017;27(12):774-784.

    Not in our library10.1089/ars.2017.7305 (opens in a new tab)

  5. 5.

    Huang H, et al. Getting a grip on adhesion: cadherin switching and collagen signaling. Biochim Biophys Acta Mol Cell Res. 2019;1866(11):118472.

    Not in our library10.1016/j.bbamcr.2019.04.002 (opens in a new tab)

  6. 6.

    Leitinger B. Discoidin domain receptor functions in physiological and pathological conditions. Int Rev Cell Mol Biol. 2014;310:39-87.

    Not in our library10.1016/b978-0-12-800180-6.00002-5 (opens in a new tab)

  7. 7.

    Valiathan RR, et al. Discoidin domain receptor tyrosine kinases: new players in cancer progression. Cancer Metastasis Rev. 2012;31(1–2):295-321.

    Not in our library10.1007/s10555-012-9346-z (opens in a new tab)

  8. 8.

    Huo Y, et al. High expression of DDR1 is associated with the poor prognosis in Chinese patients with pancreatic ductal adenocarcinoma. J Exp Clin Cancer Res. 2015;34:88.

    Not in our library10.1186/s13046-015-0202-1 (opens in a new tab)

  9. 9.

    Shintani Y, et al. Collagen I-mediated up-regulation of N-cadherin requires cooperative signals from integrins and discoidin domain receptor 1. J Cell Biol. 2008;180(6):1277-1289.

    Not in our library10.1083/jcb.200708137 (opens in a new tab)

  10. 10.

    Huang H, et al. Up-regulation of N-cadherin by collagen I-activated discoidin domain receptor 1 in pancreatic cancer requires the adaptor molecule Shc1. J Biol Chem. 2016;291(44):23208-23223.

    Not in our library10.1074/jbc.m116.740605 (opens in a new tab)

  11. 11.

    Ruggeri JM, et al. Discoidin domain receptor 1 (DDR1) is necessary for tissue homeostasis in pancreatic injury and pathogenesis of pancreatic ductal adenocarcinoma. Am J Pathol. 2020;190(8):1735-1751.

    Not in our library10.1016/j.ajpath.2020.03.020 (opens in a new tab)

  12. 12.

    Aguilera KY, et al. Inhibition of discoidin domain receptor 1 reduces collagen-mediated tumorigenicity in pancreatic ductal adenocarcinoma. Mol Cancer Ther. 2017;16(11):2473-2485.

    Not in our library10.1158/1535-7163.mct-16-0834 (opens in a new tab)

  13. 13.

    Lambert AW, et al. Emerging biological principles of metastasis. Cell. 2017;168(4):670-691.

    Not in our library10.1016/j.cell.2016.11.037 (opens in a new tab)

  14. 14.
    Tumor-Associated Macrophages and Neutrophils in Tumor Microenvironment · 2016
    No notice
  15. 15.

    Kolaczkowska E, Kubes P. Neutrophil recruitment and function in health and inflammation. Nat Rev Immunol. 2013;13(3):159-175.

    Not in our library10.1038/nri3399 (opens in a new tab)

  16. 16.

    Papayannopoulos V. Neutrophil extracellular traps in immunity and disease. Nat Rev Immunol. 2018;18(2):134-147.

    Not in our library10.1038/nri.2017.105 (opens in a new tab)

  17. 17.

    Cedervall J, Olsson AK. Immunity gone astray — NETs in cancer. Trends Cancer. 2016;2(11):633-634.

    Not in our library10.1016/j.trecan.2016.10.012 (opens in a new tab)

  18. 18.

    Tohme S, et al. Neutrophil extracellular traps promote the development and progression of liver metastases after surgical stress. Cancer Res. 2016;76(6):1367-1380.

    Not in our library10.1158/0008-5472.can-15-1591 (opens in a new tab)

  19. 19.

    Cools-Lartigue J, et al. Neutrophil extracellular traps sequester circulating tumor cells and promote metastasis. J Clin Invest.

    Not in our library10.1172/jci67484 (opens in a new tab)

  20. 20.

    Albrengues J, et al. Neutrophil extracellular traps produced during inflammation awaken dormant cancer cells in mice. Science. 2018;361(6409):eaao4227.

    Not in our library10.1126/science.aao4227 (opens in a new tab)

  21. 21.

    Park J, et al. Cancer cells induce metastasis-supporting neutrophil extracellular DNA traps. Sci Transl Med. 2016;8(361):361ra138.

    Not in our library10.1126/scitranslmed.aag1711 (opens in a new tab)

  22. 22.

    Yang L, et al. DNA of neutrophil extracellular traps promotes cancer metastasis via CCDC25. Nature. 2020;583(7814):133-138.

    Not in our library10.1038/s41586-020-2394-6 (opens in a new tab)

  23. 23.

    Boone BA, et al. The receptor for advanced glycation end products (RAGE) enhances autophagy and neutrophil extracellular traps in pancreatic cancer. Cancer Gene Ther. 2015;22(6):326-334.

    Not in our library10.1038/cgt.2015.21 (opens in a new tab)

  24. 24.

    Demers M, Wagner DD. Neutrophil extracellular traps: a new link to cancer-associated thrombosis and potential implications for tumor progression. Oncoimmunology. 2013;2(2):e22946.

    Not in our library10.4161/onci.22946 (opens in a new tab)

  25. 25.

    Miller-Ocuin JL, et al. DNA released from neutrophil extracellular traps (NETs) activates pancreatic stellate cells and enhances pancreatic tumor growth. Oncoimmunology. 2019;8(9):e1605822.

    Not in our library10.1080/2162402x.2019.1605822 (opens in a new tab)

  26. 26.

    Sivanandham R, et al. Neutrophil extracellular trap production contributes to pathogenesis in SIV-infected nonhuman primates. J Clin Invest. 2018;128(11):5178-5183.

    Not in our library10.1172/jci99420 (opens in a new tab)

  27. 27.

    Li X, et al. Extracellular lumican inhibits pancreatic cancer cell growth and is associated with prolonged survival after surgery. Clin Cancer Res. 2014;20(24):6529-6540.

    Not in our library10.1158/1078-0432.ccr-14-0970 (opens in a new tab)

  28. 28.

    Zhou SL, et al. Overexpression of CXCL5 mediates neutrophil infiltration and indicates poor prognosis for hepatocellular carcinoma. Hepatology. 2012;56(6):2242-2254.

    Not in our library10.1002/hep.25907 (opens in a new tab)

  29. 29.

    Papayannopoulos V, et al. Neutrophil elastase and myeloperoxidase regulate the formation of neutrophil extracellular traps. J Cell Biol. 2010;191(3):677-691.

    Not in our library10.1083/jcb.201006052 (opens in a new tab)

  30. 30.

    Li P, et al. PAD4 is essential for antibacterial innate immunity mediated by neutrophil extracellular traps. J Exp Med. 2010;207(9):1853-1862.

    Not in our library10.1084/jem.20100239 (opens in a new tab)

  31. 31.

    Brinkmann V, et al. Neutrophil extracellular traps kill bacteria. Science. 2004;303(5663):1532-1535.

    Not in our library10.1126/science.1092385 (opens in a new tab)

  32. 32.

    Roca H, et al. Apoptosis-induced CXCL5 accelerates inflammation and growth of prostate tumor metastases in bone. J Clin Invest. 2018;128(1):248-266.

    Not in our library10.1172/jci92466 (opens in a new tab)

  33. 33.

    Das S, et al. Discoidin domain receptor 1 receptor tyrosine kinase induces cyclooxygenase-2 and promotes chemoresistance through nuclear factor-kappaB pathway activation. Cancer Res. 2006;66(16):8123-8130.

    Not in our library10.1158/0008-5472.can-06-1215 (opens in a new tab)

  34. 34.

    Luangdilok S, et al. Syk tyrosine kinase is linked to cell motility and progression in squamous cell carcinomas of the head and neck. Cancer Res. 2007;67(16):7907-7916.

    Not in our library10.1158/0008-5472.can-07-0331 (opens in a new tab)

  35. 35.

    Ghotra VP, et al. SYK is a candidate kinase target for the treatment of advanced prostate cancer. Cancer Res. 2015;75(1):230-240.

    Not in our library10.1158/0008-5472.can-14-0629 (opens in a new tab)

  36. 36.

    Yuge R, et al. Silencing of discoidin domain receptor-1 (DDR1) concurrently inhibits multiple steps of metastasis cascade in gastric cancer. Transl Oncol. 2018;11(3):575-584.

    Not in our library10.1016/j.tranon.2018.02.003 (opens in a new tab)

  37. 37.
    Extracellular traps derived from macrophages, mast cells, eosinophils and neutrophils are generated in a time‐dependent manner during atherothrombosis · 2019
    No notice
  38. 38.

    Teijeira Á, et al. CXCR1 and CXCR2 Chemokine Receptor Agonists Produced by Tumors Induce Neutrophil Extracellular Traps that Interfere with Immune Cytotoxicity. Immunity. 2020;52(5):856-871.e8.

    Not in our library10.1016/j.immuni.2020.03.001 (opens in a new tab)

  39. 39.

    Cedervall J, et al. Neutrophil extracellular traps accumulate in peripheral blood vessels and compromise organ function in tumor-bearing animals. Cancer Res. 2015;75(13):2653-2662.

    Not in our library10.1158/0008-5472.can-14-3299 (opens in a new tab)

  40. 40.

    Li A, et al. Overexpression of CXCL5 is associated with poor survival in patients with pancreatic cancer. Am J Pathol. 2011;178(3):1340-1349.

    Not in our library10.1016/j.ajpath.2010.11.058 (opens in a new tab)

All 66 references

Cited by papers we hold 4

Questions about this paper

We email you if it is retracted, withdrawn, corrected or flagged.

Reads

Read by people on this page

None yet.

Checked or read by AI through naulon

None yet.

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.

Are you an author?

Is this your paper?

Claim it to add your note and be paid when agents cite it. Free.